Yu-Jing Liang

474 total citations
13 papers, 190 citations indexed

About

Yu-Jing Liang is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Yu-Jing Liang has authored 13 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Otorhinolaryngology, 9 papers in Oncology and 6 papers in Surgery. Recurrent topics in Yu-Jing Liang's work include Head and Neck Cancer Studies (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Diagnosis and Treatment (4 papers). Yu-Jing Liang is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Cancer Diagnosis and Treatment (4 papers). Yu-Jing Liang collaborates with scholars based in China and Taiwan. Yu-Jing Liang's co-authors include Xue-Song Sun, Qiu-Yan Chen, Xiao-Yun Li, Sai-Lan Liu, Shan-Shan Guo, Li-Ting Liu, Lin-Quan Tang, Hao‐Jun Xie, Qing-Nan Tang and Tung‐Hsi Yu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and BMC Cancer.

In The Last Decade

Yu-Jing Liang

13 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Jing Liang China 10 114 79 70 52 23 13 190
Valeria Zurlo Italy 7 98 0.9× 49 0.6× 110 1.6× 93 1.8× 2 0.1× 10 309
Suat Loo United Kingdom 7 40 0.4× 19 0.2× 32 0.5× 38 0.7× 16 0.7× 18 172
Dongmei Lin China 7 28 0.2× 49 0.6× 179 2.6× 114 2.2× 8 0.3× 15 285
Anup Kumar Bhowmick India 7 17 0.1× 43 0.5× 32 0.5× 29 0.6× 10 0.4× 17 173
Serdal Aktolga Türkiye 3 45 0.4× 67 0.8× 7 0.1× 71 1.4× 7 0.3× 3 173
Zhenyu Zou China 10 7 0.1× 145 1.8× 85 1.2× 38 0.7× 16 0.7× 25 301
Medy Tsalic Israel 7 6 0.1× 142 1.8× 78 1.1× 102 2.0× 13 0.6× 12 338
Lizhu Lin China 6 19 0.2× 46 0.6× 12 0.2× 26 0.5× 23 1.0× 14 158

Countries citing papers authored by Yu-Jing Liang

Since Specialization
Citations

This map shows the geographic impact of Yu-Jing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Jing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Jing Liang more than expected).

Fields of papers citing papers by Yu-Jing Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Jing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Jing Liang. The network helps show where Yu-Jing Liang may publish in the future.

Co-authorship network of co-authors of Yu-Jing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Jing Liang. A scholar is included among the top collaborators of Yu-Jing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Jing Liang. Yu-Jing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mai, Hai‐Qiang, Shanshan Guo, Li-Ting Liu, et al.. (2024). Neoadjuvant and adjuvant toripalimab for high-risk locoregionally advanced nasopharyngeal carcinoma: A randomized, double-blind, placebo-controlled phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). 6084–6084. 3 indexed citations
2.
Mai, Hai‐Qiang, Shanshan Guo, Xue-Song Sun, et al.. (2022). Reduced-dose radiotherapy for pretreatment EBV DNA selected low-risk stage III nasopharyngeal carcinoma: A single-arm, phase II trial.. Journal of Clinical Oncology. 40(16_suppl). 6002–6002. 10 indexed citations
3.
Sun, Xue-Song, Yu-Jing Liang, Sai-Lan Liu, et al.. (2020). Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma. Oral Oncology. 106. 104711–104711. 12 indexed citations
4.
5.
Sun, Xue-Song, Yu-Jing Liang, Sai-Lan Liu, et al.. (2019). Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance. Cancer Research and Treatment. 51(4). 1259–1268. 21 indexed citations
6.
Sun, Xue-Song, Yu-Jing Liang, Sai-Lan Liu, et al.. (2019). Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma. Oral Oncology. 94. 73–79. 14 indexed citations
7.
Liang, Yu-Jing, Xue-Song Sun, Qing-Nan Tang, et al.. (2019). Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients. Oral Oncology. 92. 40–45. 19 indexed citations
8.
Sun, Xue-Song, Sai-Lan Liu, Qiu-Yan Chen, et al.. (2019). Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study. Cancer Research and Treatment. 51(4). 1449–1463. 11 indexed citations
9.
Sun, Xue-Song, Chao Lin, Yu-Jing Liang, et al.. (2019). Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis. Oral Oncology. 97. 31–36. 3 indexed citations
10.
Sun, Xue-Song, Yu-Jing Liang, Xiao-Yun Li, et al.. (2019). <p>Palliative chemotherapy with or without anti-EGFR therapy for de novo metastatic nasopharyngeal carcinoma: a propensity score-matching study</p>. Drug Design Development and Therapy. Volume 13. 3207–3216. 10 indexed citations
11.
12.
Liu, Sai-Lan, Lin-Quan Tang, Qiu-Yan Chen, et al.. (2018). The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: results from a case-cohort study. Journal of Cancer. 9(10). 1765–1772. 3 indexed citations
13.
Lin, Li-Yun, et al.. (2008). Alpinia zerumbet Potentially Elevates High-Density Lipoprotein Cholesterol Level in Hamsters. Journal of Agricultural and Food Chemistry. 56(12). 4435–4443. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Zurlo Breakdown of academic impact, for papers by Suat Loo Breakdown of academic impact, for papers by Dongmei Lin Breakdown of academic impact, for papers by Anup Kumar Bhowmick Breakdown of academic impact, for papers by Serdal Aktolga Breakdown of academic impact, for papers by Zhenyu Zou Breakdown of academic impact, for papers by Medy Tsalic Breakdown of academic impact, for papers by Lizhu Lin
Rankless by CCL
2026